In my work coaching teams across the pharmaceutical and medical device sectors, I’ve noticed a persistent, heavy hum in the background of almost every conversation. Whether it’s a global giant or a lean biotech startup, the "thread" is unmistakable: Reduction in Force (RIF), facility closures, aggressive downsizing, and the "revolving door" of new leadership.
In the life sciences, we are used to scientific uncertainty—that’s the nature of R&D. But organizational uncertainty? That hits differently. It breeds a specific kind of paralysis that can stall innovation exactly when the company needs it most.
If you are leading a team through this right now, here is what you need to know about navigating the fog.
1. Radical Transparency (Even When You Don't Have the Answers)
The biggest mistake leaders make during a downsizing or a merger is "radio silence" until they have a perfect plan. In the absence of information, people don’t assume the best; they invent the worst.
- The Reality: You might not know if more cuts are coming.
- The Strategy: Say that. "I don't have the full roadmap yet, but I am committed to sharing what I know as soon as I am permitted to." Authenticity builds more trust than a polished corporate script.
2. Acknowledge the "Survivor’s Fatigue"
We often focus all our empathy on those leaving the organization. But those who stay—the "survivors"—are often grappling with guilt, increased workloads, and a loss of psychological safety.
- The Shift: You aren't just managing a transition; you are managing a grief cycle. * The Action: Give your team space to exhale. Acknowledge that things are harder now. Validate their frustration before asking them to pivot to the next quarterly goal.
3. Anchor to the "Why," Not Just the "What"
In life sciences, we have a unique advantage: The Patient. When facilities close and leadership shifts, the "What" (our daily tasks) becomes chaotic. To stabilize the team, you must over-index on the "Why."
| Distraction (The "What") | Anchor (The "Why") |
| "Our department was merged." | "Our clinical trials must remain integrity-rich for the patients waiting." |
| "I have a new boss every six months." | "The regulatory standards we uphold ensure the safety of millions." |
4. Focus on "Micro-Certainties"
When the five-year plan is up in the air, macro-certainty is impossible. To keep a team from spinning out, create micro-certainties. These are small, predictable wins or routines that people can rely on.
- Maintain your 1:1s: Never cancel them during a crisis; that’s when they are needed most.
- Shorten the horizon: Instead of yearly goals, focus on "What do we need to achieve in the next 14 days?"
- Define the "Non-Negotiables": Be clear about what isn’t changing—like your team’s culture of collaboration or your commitment to quality.
5. Lead with Your Own Oxygen Mask On
You cannot coach a team through a RIF if you are vibrating with unmanaged anxiety yourself. Uncertainty is emotionally expensive.
The Golden Rule of Change Leadership: Your team will mirror your nervous system. If you are frantic, they will be frantic. If you are grounded—even if you are concerned—they will find a way to stay grounded too.
The Bottom Line
Leading through the current volatility in pharma and med-tech isn't about having a "fix" for the industry's shifts. It’s about being a steady presence in an unsteady environment. You aren't just a manager of projects; you are a steward of people.
Keep the lines open, keep the mission front-and-center, and remember: stability isn't the absence of change—it's the ability to move through it together.
To schedule my "Leading Through Change & Uncertainty" workshop for your team, contact me at sharon@smwgroupllc.com

Recent Comments